{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:41:54Z","timestamp":1790786514894,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T00:00:00Z","timestamp":1724457600000},"content-version":"vor","delay-in-days":236,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IDCases"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/j.idcr.2024.e02070","type":"journal-article","created":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T02:45:58Z","timestamp":1724813158000},"page":"e02070","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Herpes zoster ophthalmicus following recombinant zoster vaccine: A case report and brief literature review"],"prefix":"10.1016","volume":"37","author":[{"given":"Joshua M.","family":"Garcia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramez I.","family":"Haddadin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.idcr.2024.e02070_bib1","doi-asserted-by":"crossref","first-page":"274","DOI":"10.4065\/84.3.274","article-title":"Herpes zoster (shingles) and postherpetic neuralgia","volume":"84","author":"Sampathkumar","year":"2009","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"10.1016\/j.idcr.2024.e02070_bib2","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3390\/v14020192","article-title":"Herpes zoster: a review of clinical manifestations and management","volume":"14","author":"Patil","year":"2022","journal-title":"Viruses"},{"issue":"5","key":"10.1016\/j.idcr.2024.e02070_bib3","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1365-2990.2011.01167.x","article-title":"Review: the neurobiology of varicella zoster virus infection","volume":"37","author":"Gilden","year":"2011","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"11","key":"10.1016\/j.idcr.2024.e02070_bib4","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.4065\/82.11.1341","article-title":"A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction","volume":"82","author":"Yawn","year":"2007","journal-title":"Mayo Clin Proc"},{"issue":"Supplement_4","key":"10.1016\/j.idcr.2024.e02070_bib5","doi-asserted-by":"crossref","first-page":"S429","DOI":"10.1093\/infdis\/jiab387","article-title":"Herpes zoster vaccines","volume":"224","author":"Harbecke","year":"2021","journal-title":"J Infect Dis"},{"key":"10.1016\/j.idcr.2024.e02070_bib6","doi-asserted-by":"crossref","first-page":"k4029","DOI":"10.1136\/bmj.k4029","article-title":"Efficacy, effectiveness, and safety of herpes zoster vaccines in adults aged 50 and older: systematic review and network meta-analysis","volume":"363","author":"Tricco","year":"2018","journal-title":"BMJ"},{"issue":"8","key":"10.1016\/j.idcr.2024.e02070_bib7","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1080\/21645515.2017.1317410","article-title":"A critical appraisal of \u201cShingrix\u201d, a novel herpes zoster subunit vaccine (HZ\/Su or GSK1437173A) for varicella zoster virus","volume":"13","author":"Bharucha","year":"2017","journal-title":"Hum Vaccin Immunother"},{"issue":"11","key":"10.1016\/j.idcr.2024.e02070_bib8","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1093\/infdis\/jiy095","article-title":"Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older","volume":"217","author":"Cunningham","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.idcr.2024.e02070_bib9","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.mm6703a5","article-title":"Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines","volume":"67","author":"Dooling","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.idcr.2024.e02070_bib10","series-title":"StatPearls","article-title":"Herpes Zoster","author":"Nair","year":"2023"},{"key":"10.1016\/j.idcr.2024.e02070_bib11","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.coi.2019.02.009","article-title":"Understanding the immunology of Shingrix, a recombinant glycoprotein E adjuvanted herpes zoster vaccine","volume":"59","author":"Heineman","year":"2019","journal-title":"Curr Opin Immunol"},{"issue":"12","key":"10.1016\/j.idcr.2024.e02070_bib12","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s40264-021-01118-3","article-title":"An analysis of spontaneously reported data of vesicular and bullous cutaneous eruptions occurring following vaccination with the adjuvanted recombinant zoster vaccine","volume":"44","author":"Pirrotta","year":"2021","journal-title":"Drug Saf"},{"issue":"1","key":"10.1016\/j.idcr.2024.e02070_bib13","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaa005","article-title":"Risk factors for herpes zoster infection: a meta-analysis","volume":"7","author":"Marra","year":"2020","journal-title":"Open Forum Infect Dis"},{"issue":"47","key":"10.1016\/j.idcr.2024.e02070_bib14","doi-asserted-by":"crossref","first-page":"7455","DOI":"10.1016\/j.vaccine.2020.09.073","article-title":"Blistering autoimmune skin reaction following SHINGRIX vaccination in an ulcerative colitis patient: case report and literature review","volume":"38","author":"Bell","year":"2020","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.idcr.2024.e02070_bib15","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2020-241293","article-title":"Bullous fixed drug eruption following administration of the recombinant adjuvant Shingrix vaccine","volume":"14","author":"Thompson","year":"2021","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.idcr.2024.e02070_bib16","doi-asserted-by":"crossref","unstructured":"Mittal N., Dhir N., Mittal N. Dermatomal rash after Shingrix vaccination: cause or coincidence? Proc (Bayl Univ Med Cent). 35(5):686\u2013687. doi:10.1080\/08998280.2022.2071118.","DOI":"10.1080\/08998280.2022.2071118"},{"key":"10.1016\/j.idcr.2024.e02070_bib17","doi-asserted-by":"crossref","unstructured":"Altukhaim F., Mutlaq M., Alghamdi M., Hakami S. Reactivation of Herpes Zoster After Recombinant Vaccine (Shingrix): A Case Report. Cureus. 15(1):e34431. doi:10.7759\/cureus.34431.","DOI":"10.7759\/cureus.34431"},{"issue":"1","key":"10.1016\/j.idcr.2024.e02070_bib18","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/ICB.0000000000000729","article-title":"Acute retinal necrosis and contralateral cutaneous eruption after the shingles vaccine","volume":"15","author":"Ali","year":"2021","journal-title":"Retin Cases Brief Rep"},{"issue":"6","key":"10.1016\/j.idcr.2024.e02070_bib19","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1097\/ICO.0000000000001203","article-title":"Reactivation of herpes zoster keratitis with corneal perforation after zoster vaccination","volume":"36","author":"Jastrzebski","year":"2017","journal-title":"Cornea"},{"key":"10.1016\/j.idcr.2024.e02070_bib20","doi-asserted-by":"crossref","unstructured":"Jabbour, Samir MD, CM, FRCSC; Shekhawat, Nakul S. MD, MPH; Chen, Ariel MD; Woreta, Fasika A. MD, MPH. Presumed Herpes Zoster Ophthalmicus Reactivation Following Recombinant Zoster Vaccination. Cornea 40(2):p 248\u2013250, February 2021. DOI:10.1097\/ICO.0000000000002537.","DOI":"10.1097\/ICO.0000000000002537"}],"container-title":["IDCases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221425092400146X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221425092400146X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T10:16:20Z","timestamp":1741083380000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221425092400146X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":20,"alternative-id":["S221425092400146X"],"URL":"https:\/\/doi.org\/10.1016\/j.idcr.2024.e02070","relation":{},"ISSN":["2214-2509"],"issn-type":[{"value":"2214-2509","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Herpes zoster ophthalmicus following recombinant zoster vaccine: A case report and brief literature review","name":"articletitle","label":"Article Title"},{"value":"IDCases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idcr.2024.e02070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e02070"}}